Evidence map›Paper›PMID 24490151›Full record

ArticleBioMed research international2013

Molecular modeling of lectin-like protein from Acacia farnesiana reveals a possible anti-inflammatory mechanism in Carrageenan-induced inflammation.

Vanessa Erika Ferreira Abrantes, Bruno Anderson Matias da Rocha, Raphael Batista da Nóbrega, José Caetano Silva-Filho, Claudener Souza Teixeira, Benildo Sousa Cavada, Carlos Alberto de Almeida Gadelha, Sergio Henrique Ferreira, Jozi Godoy Figueiredo, Tatiane Santi-Gadelha and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. A Review of the Leishmanicidal Properties of Lectins.Current protein & peptide science · 2024
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Vanessa Erika Ferreira AbrantesDepartamento de Biologia Molecular, Universidade Federal da Paraíba, Campus I, Cidade Universitária, 58059-900 João Pessoa, PB, Brazil.
Bruno Anderson Matias da RochaDepartamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, BioMol-Lab, Campus do Pici S/N, 60440-970 Fortaleza, CE, Brazil.
Raphael Batista da NóbregaDepartamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, BioMol-Lab, Campus do Pici S/N, 60440-970 Fortaleza, CE, Brazil.
José Caetano Silva-FilhoDepartamento de Biologia Molecular, Universidade Federal da Paraíba, Campus I, Cidade Universitária, 58059-900 João Pessoa, PB, Brazil.
Claudener Souza TeixeiraDepartamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, BioMol-Lab, Campus do Pici S/N, 60440-970 Fortaleza, CE, Brazil.
Benildo Sousa CavadaDepartamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, BioMol-Lab, Campus do Pici S/N, 60440-970 Fortaleza, CE, Brazil.
Carlos Alberto de Almeida GadelhaDepartamento de Biologia Molecular, Universidade Federal da Paraíba, Campus I, Cidade Universitária, 58059-900 João Pessoa, PB, Brazil.
Sergio Henrique FerreiraDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049-900 Ribeirão Preto, SP, Brazil.
Jozi Godoy FigueiredoDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049-900 Ribeirão Preto, SP, Brazil.
Tatiane Santi-GadelhaDepartamento de Biologia Molecular, Universidade Federal da Paraíba, Campus I, Cidade Universitária, 58059-900 João Pessoa, PB, Brazil.
Plinio DelatorreDepartamento de Biologia Molecular, Universidade Federal da Paraíba, Campus I, Cidade Universitária, 58059-900 João Pessoa, PB, Brazil.
Universidade Federal da Paraíba · BRUniversidade Federal do Ceará · BRUniversidade de Ribeirão Preto · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acacia farnesiana lectin-like protein (AFAL) is a chitin-binding protein and has been classified as phytohaemagglutinin from Phaseolus vulgaris (PHA). Legume lectins are examples for structural studies, and this family of proteins shows a remarkable conservation in primary, secondary, and tertiary structures. Lectins have ability to reduce the effects of inflammation caused by phlogistic agents, such as carrageenan (CGN). This paper explains the anti-inflammatory activity of AFAL through structural comparison with anti-inflammatory legume lectins. The AFAL model was obtained by molecular modeling and molecular docking with glycan and carrageenan were performed to explain the AFAL structural behavior and biological activity. Pisum sativum lectin was the best template for molecular modeling. The AFAL structure model is folded as a β sandwich. The model differs from template in loop regions, number of β strands and carbohydrate-binding site. Carrageenan and glycan bind to different sites on AFAL. The ability of AFAL binding to carrageenan can be explained by absence of the sixth β -strand (posterior β sheets) and two β strands in frontal region. AFAL can inhibit pathway inflammatory process by carrageenan injection by connecting to it and preventing its entry into the cell and triggers the reaction.

Indexed as

Models, MolecularAcaciaAnimalsAnti-Inflammatory AgentsCarrageenanChitinCrystallography, X-RayInflammationMiceMolecular Docking SimulationPhytohemagglutininsPlant LectinsProtein BindingAnti-Inflammatory AgentsCarrageenanChitinPhytohemagglutininsPlant Lectins

Identifiers

PMID24490151
PMCPMC3893743
OpenAlexW2154782268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.